Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.
Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...
Alcohol-related health issues surged during the COVID-19 pandemic, with a 17.6% rise in mortality, calling for enhanced ...
Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...
Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.
President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...
Draped in Mexican and Salvadoran flags, roughly 1,000 demonstrators gathered near City Hall shortly before noon, blocking ...
Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into effect, to counter increasing costs of manufacturing ...
Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...
We recently published a list of Jim Cramer’s Latest Calls: 10 Stocks to Buy or Sell. In this article, we are going to take a ...
Videos circulating online used a clip from the parody site The Onion to falsely claim that Pope Francis has appointed Cardinal Luis Antonio Tagle as his successor Claim: Pope Francis has resigned ...
TORONTO - A synthetic dye newly banned from the U.S. food supply will remain available in Canada, where the federal regulator has deemed it is not a health risk to the general population.